Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Surgalign Holdings's share price for the quarter that ended in Mar. 2023 was $1.6. Surgalign Holdings's Shares Outstanding (EOP) for the quarter that ended in Mar. 2023 was 9.18 Mil. Therefore, Surgalign Holdings's market cap for the quarter that ended in Mar. 2023 was $14.68 Mil.
Surgalign Holdings's quarterly market cap
declined
from Sep. 2022 ($23.49 Mil) to Dec. 2022 ($15.64 Mil) and
declined
from Dec. 2022 ($15.64 Mil) to Mar. 2023 ($14.68 Mil).
Surgalign Holdings's annual market cap
declined
from Dec. 2020 ($178.87 Mil) to Dec. 2021 ($105.05 Mil) and
declined
from Dec. 2021 ($105.05 Mil) to Dec. 2022 ($15.64 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Surgalign Holdings's Enterprise Value for Today is $-12.02 Mil.
Surgalign Holdings Market Cap Historical Data
The historical data trend for Surgalign Holdings's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Surgalign Holdings's Market Cap
For the Medical Devices subindustry, Surgalign Holdings's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Surgalign Holdings's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Surgalign Holdings's Market Cap distribution charts can be found below:
* The bar in red indicates where Surgalign Holdings's Market Cap falls into.
Surgalign Holdings Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Surgalign Holdings's Market Cap for the fiscal year that ended in Dec. 2022 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Surgalign Holdings (OTCPK:SRGAQ) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Surgalign Holdings Market Cap Related Terms
Thank you for viewing the detailed overview of Surgalign Holdings's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Surgalign Holdings (Surgalign Holdings) Business Description
Surgalign Holdings Inc is a global medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. The company continues to invest in clinically validated innovation to deliver the Best surgical outcomes and improve patient's lives. It markets products throughout the United States and in more than 50 countries worldwide through an expanding network of top independent distributors. The U.S. market accounts for the vast majority of revenue. It has commercial and design centers in San Diego, California, and Wurmlingen, Germany.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
SRGAQ has been successfully added to your 